Cargando…
Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient
Pseudomonas aeruginosa chronically infects the lungs of cystic fibrosis (CF) patients. The conditions in the CF lung appear to select for P. aeruginosa with advantageous phenotypes for chronic infection. However, the mechanisms that allow the establishment of this chronic infection have not been ful...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149151/ https://www.ncbi.nlm.nih.gov/pubmed/21863142 http://dx.doi.org/10.3389/fmicb.2011.00162 |
_version_ | 1782209430953132032 |
---|---|
author | Rao, Jayasimha Damron, F. Heath Basler, Marek DiGiandomenico, Antonio Sherman, Nicholas E. Fox, Jay W. Mekalanos, John J. Goldberg, Joanna B. |
author_facet | Rao, Jayasimha Damron, F. Heath Basler, Marek DiGiandomenico, Antonio Sherman, Nicholas E. Fox, Jay W. Mekalanos, John J. Goldberg, Joanna B. |
author_sort | Rao, Jayasimha |
collection | PubMed |
description | Pseudomonas aeruginosa chronically infects the lungs of cystic fibrosis (CF) patients. The conditions in the CF lung appear to select for P. aeruginosa with advantageous phenotypes for chronic infection. However, the mechanisms that allow the establishment of this chronic infection have not been fully characterized. We have previously reported the transcriptional analysis of two CF isolates strains 383 and 2192. Strain 2192 is a mucoid, alginate overproducing strain whereas strain 383 is non-mucoid. Mucoid strains are associated with chronic infection of the CF lung and non-mucoid strains are the typical initially infecting isolates. To elucidate novel differences between these two strains, we employed two methods of shotgun proteomics: isobaric tags for relative and absolute quantitation (iTRAQ) and two-dimensional gel electrophoresis (2-DE). iTRAQ compares the amount of protein between samples and relies on protein abundance, while 2-DE gel electrophoresis depends on selection of separated protein spots. For both these methods, mass spectrometry was then used to identify proteins differentially expressed between the two strains. The compilation of these two proteomic methods along with Western blot analysis revealed proteins of the HSI-I operon of the type 6 secretion system, showed increased expression in 383 compared to 2192, confirming the our previous transcriptional analysis. Proteomic analysis of other proteins did not fully correlate with the transcriptome but other differentially expressed proteins are discussed. Also, differences were noted between the results obtained for the two proteomic techniques. These shotgun proteomic analyses identified proteins that had been predicted only through gene identification; we now refer to these as “proteins of unknown functions” since their existence has now been established however their functional characterization remains to be elucidated. |
format | Online Article Text |
id | pubmed-3149151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Frontiers Research Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-31491512011-08-23 Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient Rao, Jayasimha Damron, F. Heath Basler, Marek DiGiandomenico, Antonio Sherman, Nicholas E. Fox, Jay W. Mekalanos, John J. Goldberg, Joanna B. Front Microbiol Microbiology Pseudomonas aeruginosa chronically infects the lungs of cystic fibrosis (CF) patients. The conditions in the CF lung appear to select for P. aeruginosa with advantageous phenotypes for chronic infection. However, the mechanisms that allow the establishment of this chronic infection have not been fully characterized. We have previously reported the transcriptional analysis of two CF isolates strains 383 and 2192. Strain 2192 is a mucoid, alginate overproducing strain whereas strain 383 is non-mucoid. Mucoid strains are associated with chronic infection of the CF lung and non-mucoid strains are the typical initially infecting isolates. To elucidate novel differences between these two strains, we employed two methods of shotgun proteomics: isobaric tags for relative and absolute quantitation (iTRAQ) and two-dimensional gel electrophoresis (2-DE). iTRAQ compares the amount of protein between samples and relies on protein abundance, while 2-DE gel electrophoresis depends on selection of separated protein spots. For both these methods, mass spectrometry was then used to identify proteins differentially expressed between the two strains. The compilation of these two proteomic methods along with Western blot analysis revealed proteins of the HSI-I operon of the type 6 secretion system, showed increased expression in 383 compared to 2192, confirming the our previous transcriptional analysis. Proteomic analysis of other proteins did not fully correlate with the transcriptome but other differentially expressed proteins are discussed. Also, differences were noted between the results obtained for the two proteomic techniques. These shotgun proteomic analyses identified proteins that had been predicted only through gene identification; we now refer to these as “proteins of unknown functions” since their existence has now been established however their functional characterization remains to be elucidated. Frontiers Research Foundation 2011-08-01 /pmc/articles/PMC3149151/ /pubmed/21863142 http://dx.doi.org/10.3389/fmicb.2011.00162 Text en Copyright © 2011 Rao, Damron, Basler, DiGiandomenico, Sherman, Fox, Mekalanos and Goldberg. http://www.frontiersin.org/licenseagreement This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with. |
spellingShingle | Microbiology Rao, Jayasimha Damron, F. Heath Basler, Marek DiGiandomenico, Antonio Sherman, Nicholas E. Fox, Jay W. Mekalanos, John J. Goldberg, Joanna B. Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient |
title | Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient |
title_full | Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient |
title_fullStr | Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient |
title_full_unstemmed | Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient |
title_short | Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient |
title_sort | comparisons of two proteomic analyses of non-mucoid and mucoid pseudomonas aeruginosa clinical isolates from a cystic fibrosis patient |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149151/ https://www.ncbi.nlm.nih.gov/pubmed/21863142 http://dx.doi.org/10.3389/fmicb.2011.00162 |
work_keys_str_mv | AT raojayasimha comparisonsoftwoproteomicanalysesofnonmucoidandmucoidpseudomonasaeruginosaclinicalisolatesfromacysticfibrosispatient AT damronfheath comparisonsoftwoproteomicanalysesofnonmucoidandmucoidpseudomonasaeruginosaclinicalisolatesfromacysticfibrosispatient AT baslermarek comparisonsoftwoproteomicanalysesofnonmucoidandmucoidpseudomonasaeruginosaclinicalisolatesfromacysticfibrosispatient AT digiandomenicoantonio comparisonsoftwoproteomicanalysesofnonmucoidandmucoidpseudomonasaeruginosaclinicalisolatesfromacysticfibrosispatient AT shermannicholase comparisonsoftwoproteomicanalysesofnonmucoidandmucoidpseudomonasaeruginosaclinicalisolatesfromacysticfibrosispatient AT foxjayw comparisonsoftwoproteomicanalysesofnonmucoidandmucoidpseudomonasaeruginosaclinicalisolatesfromacysticfibrosispatient AT mekalanosjohnj comparisonsoftwoproteomicanalysesofnonmucoidandmucoidpseudomonasaeruginosaclinicalisolatesfromacysticfibrosispatient AT goldbergjoannab comparisonsoftwoproteomicanalysesofnonmucoidandmucoidpseudomonasaeruginosaclinicalisolatesfromacysticfibrosispatient |